Translational Development Acquisition Stock Price, News & Analysis
TDAC
NASDAQ
Company Description
Information about Translational Development Acquisition (Ticker: TDAC).
This is where the company description would appear. The company description provides an overview of the business, its operations, market position, and key products or services.
The full company description can be quite extensive, often including information about the company's history, leadership team, industry context, competitive advantages, business model, and future outlook. This section is designed to give investors a comprehensive understanding of the company's position in the market.
Stock Performance
$10.12
0.00%
0.00
Last updated: April 27, 2025 at 11:23
- %
Performance 1 year
$221.3M
Market Cap
21.9M
Shares outstanding
Latest News
SEC Filings
No SEC filings available for Translational Development Acquisition.
Financial Highlights
$4,294,488
Net Income (TTM)
-$194,805
Operating Cash Flow
0.02
Current Ratio
-$590,217
Operating Income
—
Revenue (TTM)
—
Diluted EPS (TTM)
Upcoming Events
Frequently Asked Questions
What is the current stock price of Translational Development Acquisition (TDAC)?
The current stock price of Translational Development Acquisition (TDAC) is $10.12 as of April 25, 2025.
What is the market cap of Translational Development Acquisition (TDAC)?
The market cap of Translational Development Acquisition (TDAC) is approximately 221.3M.
What is the net income of Translational Development Acquisition (TDAC)?
The trailing twelve months (TTM) net income of Translational Development Acquisition (TDAC) is $4,294,488.
What is the operating cash flow of Translational Development Acquisition (TDAC)?
The operating cash flow of Translational Development Acquisition (TDAC) is -$194,805.
What is the current ratio of Translational Development Acquisition (TDAC)?
The current ratio of Translational Development Acquisition (TDAC) is 0.02, indicating the company's ability to pay short-term obligations.
What is the operating income of Translational Development Acquisition (TDAC)?
The operating income of Translational Development Acquisition (TDAC) is -$590,217.